Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Toxoplasmosis and the compromised host.

R Viens, R Morisset

    International Journal of Clinical Pharmacology and Biopharmacy
    |June 1, 1975
    PubMed
    Summary
    This summary is machine-generated.

    Most people have antibodies to Toxoplasma gondii, but serious illness is rare. Immunocompromised patients require screening and treatment for toxoplasmosis to prevent severe outcomes.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Prevalence of and risk factors for sexually-transmitted infections in hidden female sex workers.

    Medecine et maladies infectieuses·2009
    Same author

    Sustained interleukin-6 and interleukin-8 expression following infection with Chlamydia trachomatis serovar L2 in a HeLa/THP-1 cell co-culture model.

    Scandinavian journal of immunology·2006
    Same author

    Virus load correlates inversely with the expression of cytotoxic T lymphocyte activation markers in HIV-1-infected/AIDS patients showing MHC-unrestricted CTL-mediated lysis.

    Clinical and experimental immunology·2003
    Same author

    Modulation of expression of the MHC class I-binding natural killer cell receptors, and NK activity in relation to viral load in HIV-infected/AIDS patients.

    Journal of medical virology·2001
    Same author

    Evidence for a correlation between antibody-dependent cellular cytotoxicity-mediating anti-HIV-1 antibodies and prognostic predictors of HIV infection.

    Journal of clinical immunology·2001
    Same author

    [In vitro inhibition of Chlamydia trachomatis growth by liposome-encapsulated cyclines].

    Pathologie-biologie·2001

    Area of Science:

    • Medical Parasitology
    • Immunology
    • Infectious Diseases

    Background:

    • High seroprevalence of Toxoplasma gondii antibodies in the general population.
    • Clinical manifestations of primary toxoplasmosis are infrequent.
    • Congenital and secondary toxoplasmosis, such as chorioretinitis, pose significant health risks.

    Purpose of the Study:

    • To highlight the importance of screening and managing toxoplasmosis in at-risk populations.
    • To emphasize the potential severity of toxoplasmosis in immunocompromised individuals.

    Main Methods:

    • Clinical observation and serological screening of patients.
    • Monitoring of patients undergoing immunosuppressive therapy.

    Main Results:

    Related Experiment Videos

    • While primary infections are often asymptomatic, toxoplasmosis can be severe or fatal in compromised hosts.
    • Congenital and secondary forms present serious medical conditions.

    Conclusions:

    • Patients undergoing immunosuppressive therapy or with pathological immune suppression necessitate clinical and serological screening for toxoplasmosis.
    • Prophylactic or therapeutic treatment for toxoplasmosis is crucial throughout the period of immunosuppression to prevent severe morbidity and mortality.